018455761

ORZELIA

---

April 18, 2021

Trademark Summary

The trademark ORZELIA was filed by SPERO THERAPEUTICS, INC., a U.S. corporation (the "Applicant"). The application was published for oppositions on June 1, 2021, and received one opposition filed on September 1, 2021 by Bristol-Myers Squibb Company on Likelihood of confusion. the opponent was represented by HOGAN LOVELLS and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 1, 2021

The application was filed in English, and English was also language of all opposition proceedings (Italian was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical preparations, namely, antibiotics.
• The mark was filed in class 42 with Pharmaceutical research services and Pharmaceutical drug development service..